1. Home
  2. GDTC vs CGBS Comparison

GDTC vs CGBS Comparison

Compare GDTC & CGBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • CGBS
  • Stock Information
  • Founded
  • GDTC 2018
  • CGBS 2018
  • Country
  • GDTC Singapore
  • CGBS Jersey
  • Employees
  • GDTC N/A
  • CGBS N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • CGBS
  • Sector
  • GDTC Health Care
  • CGBS
  • Exchange
  • GDTC Nasdaq
  • CGBS Nasdaq
  • Market Cap
  • GDTC 28.0M
  • CGBS 30.9M
  • IPO Year
  • GDTC 2023
  • CGBS N/A
  • Fundamental
  • Price
  • GDTC $2.05
  • CGBS $0.06
  • Analyst Decision
  • GDTC Buy
  • CGBS
  • Analyst Count
  • GDTC 1
  • CGBS 0
  • Target Price
  • GDTC $5.00
  • CGBS N/A
  • AVG Volume (30 Days)
  • GDTC 6.7K
  • CGBS 39.7M
  • Earning Date
  • GDTC 01-01-0001
  • CGBS 01-01-0001
  • Dividend Yield
  • GDTC N/A
  • CGBS N/A
  • EPS Growth
  • GDTC N/A
  • CGBS N/A
  • EPS
  • GDTC N/A
  • CGBS N/A
  • Revenue
  • GDTC $368,838.00
  • CGBS N/A
  • Revenue This Year
  • GDTC $5.37
  • CGBS N/A
  • Revenue Next Year
  • GDTC N/A
  • CGBS N/A
  • P/E Ratio
  • GDTC N/A
  • CGBS N/A
  • Revenue Growth
  • GDTC N/A
  • CGBS N/A
  • 52 Week Low
  • GDTC $1.20
  • CGBS $0.06
  • 52 Week High
  • GDTC $4.05
  • CGBS $3.78
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 45.73
  • CGBS N/A
  • Support Level
  • GDTC $2.12
  • CGBS N/A
  • Resistance Level
  • GDTC $2.22
  • CGBS N/A
  • Average True Range (ATR)
  • GDTC 0.09
  • CGBS 0.00
  • MACD
  • GDTC -0.00
  • CGBS 0.00
  • Stochastic Oscillator
  • GDTC 28.57
  • CGBS 0.00

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About CGBS Crown LNG Holdings Limited Ordinary Shares

Crown LNG Holdings Ltd is an LNG infrastructure company that seeks to provide natural gas liquefaction, storage, and re-gasification services. It focuses on enabling a stable and reliable supply of LNG to customers, especially in geographic areas where onshore or floating facilities may be difficult or less desirable as a result of harsh weather conditions, safety or environmental concerns, or cost. It specializes in the design and operation of offshore, all-weather LNG liquefication and re-gasification terminals, such as gravity-based structures. Through Its technologies and design, It believes it can deliver tailored LNG infrastructure suitable for energy-isolated locations, as well as provide critical LNG infrastructure to under-served markets around the world.

Share on Social Networks: